How to Choose the Right ED Treatment Based on Age & Health
Updated: Sep 23
Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer Mar 20 2026
Erectile dysfunction (ED) becomes more common with age, but getting older does not automatically determine which treatment will work best. The right approach depends more on the cause of ED, cardiovascular health, medicines, diabetes, hormone status, prostate treatment history, kidney or liver function, and personal preferences. When considering ED treatment based on age and health, oral medicines called PDE5 inhibitors—such as sildenafil and tadalafil—are first-line treatments for many men, but they are not appropriate for everyone. Current European Association of Urology (EAU) guidance also emphasizes lifestyle and cardiovascular risk assessment because ED can sometimes be an early marker of cardiovascular disease. Men who cannot use or do not respond to tablets have several evidence-based alternatives, including vacuum devices, injections, and penile implants. This guide explains how age and common health conditions influence those choices without assuming that one ED treatment is best for every man.
Why Does Age Matter When Choosing ED Treatment?
Age matters mainly because the health conditions and medicines associated with ED become more common over time. Age alone does not determine whether someone should use sildenafil, tadalafil, a vacuum device, injections, or another treatment.
Blood-vessel disease, diabetes, high blood pressure, medication use, prostate conditions, and hormonal problems can all contribute to ED. Current EAU guidance recommends evaluating medical and sexual history and looking for relevant cardiovascular and metabolic conditions rather than treating ED as an isolated symptom.
The 2026 EAU Sexual and Reproductive Health Guidelines identify PDE5 inhibitors as first-line drug therapy while also recommending lifestyle changes and modification of relevant risk factors alongside ED treatment.
ED in younger adults
Persistent ED in a younger man deserves proper evaluation rather than automatically being attributed to anxiety.
Psychological factors, relationship concerns, medications, substance use, hormonal disorders, and vascular or metabolic problems can all contribute. The relative importance of these factors varies considerably between individuals.
Cardiovascular assessment can be particularly relevant when ED appears unexpectedly without an obvious explanation. Current European guidance describes ED as a potential precursor or risk marker for cardiovascular disease, including among younger men.
ED in middle age
During middle age, cardiovascular and metabolic factors often become increasingly important. High blood pressure, diabetes, abnormal cholesterol, obesity, smoking, and physical inactivity can affect the blood vessels needed for normal erections.
Treatment therefore should not focus solely on producing an erection. ED evaluation can also provide an opportunity to identify previously unrecognized cardiovascular risk factors.
ED in older adults
Older age does not prevent effective ED treatment. Many older men can use PDE5 inhibitors, provided their cardiovascular status and medicines make these drugs appropriate.
Medication review becomes especially important because older adults are more likely to use nitrates, alpha-blockers, blood-pressure medicines, and multiple other prescriptions. Kidney or liver impairment can also affect how some ED medicines are handled by the body.
There is no “best ED pill for your age.” A healthy 70-year-old and a 50-year-old with significant heart disease may require very different decisions. Cardiovascular status, other illnesses, medications, the cause of ED, and personal priorities usually provide more useful guidance than age alone.
Which ED Treatments Are Available?
ED treatment ranges from lifestyle and psychological interventions to oral medicines, vacuum devices, penile injections, and surgery. Current guidelines encourage shared decision-making because effectiveness, convenience, invasiveness, side effects, cost, and personal preferences differ between options.
Treatment | General role | Important considerations |
PDE5 inhibitors | First-line drug treatment for many men | Cannot be combined with nitrates; cardiovascular and medication review matters |
Lifestyle/risk-factor management | Addresses potentially reversible contributors | Particularly relevant with obesity, smoking, inactivity or cardiovascular risk |
Psychological/sex therapy | Useful when psychological or relationship factors contribute | Can be combined with medical treatment |
Vacuum erection device | Drug-free mechanical option | Requires correct use and may feel less spontaneous |
Penile injections | Effective option when tablets fail or cannot be used | Requires instruction and carries risks including prolonged erection |
Intraurethral/topical alprostadil | Alternative for selected men avoiding oral treatment or injections | Availability and effectiveness vary |
Penile prosthesis | Surgical option for appropriately selected men | Usually considered after other options are unsuitable or unsuccessful |
EAU recommendations support PDE5 inhibitors as first-line treatment, intracavernosal injections as an alternative first-line option for well-informed patients or a second-line treatment, and vacuum devices for men seeking non-invasive, drug-free management.
Sildenafil, tadalafil and other PDE5 inhibitors
PDE5 inhibitors improve the normal erectile response by increasing signaling that helps penile blood vessels relax during sexual stimulation. They do not automatically produce an erection without sexual stimulation.
Sildenafil and tadalafil differ in characteristics such as how long their effects can remain clinically useful and how food influences some formulations. The best choice therefore depends partly on whether someone prefers planned treatment around sexual activity or a longer therapeutic window.
Tadalafil also has an additional role in men who have both ED and bothersome urinary symptoms related to benign prostatic enlargement. Current EAU guidance notes that tadalafil is licensed for male lower urinary tract symptoms with or without ED.
What if ED tablets do not work?
One unsuccessful attempt does not necessarily establish that PDE5 inhibitors have failed.
The AUA guideline notes that incorrect use—including inadequate sexual stimulation or issues surrounding food and administration—can contribute to treatment failure. Appropriate instructions and more than one treatment attempt may therefore be needed before effectiveness is assessed.
If properly used oral treatment remains ineffective or cannot be tolerated, current international recommendations support alternatives such as intracavernosal injections, vacuum erection devices, and penile prosthesis surgery.
How Does Heart Health Change ED Treatment?
Heart health is one of the most important considerations before ED treatment because erectile function and cardiovascular health share many vascular risk factors. ED can also precede clinically apparent cardiovascular disease in some men.
The Princeton IV recommendations on ED and cardiovascular health describe ED as a cardiovascular risk marker and recommend cardiovascular risk assessment where appropriate. They also emphasize assessing whether sexual activity itself is safe in men with significant cardiovascular disease.
Can people with heart disease take ED medicines?
Some can. Having cardiovascular disease does not automatically prohibit PDE5-inhibitor treatment.
Current evidence supports cardiovascular safety in appropriately selected patients, and European guidance reports no demonstrated increase in myocardial infarction rates in randomized or open-label PDE5-inhibitor studies.
The important issue is whether cardiovascular disease is stable enough for sexual activity and whether the person's medications interact with ED treatment. People with unstable or high-risk cardiovascular conditions may require cardiac evaluation before treatment or resuming sexual activity.
Why are nitrates and ED pills dangerous together?
PDE5 inhibitors must not be combined with organic nitrates or nitric-oxide donors because the combination can cause a dangerous fall in blood pressure.
EAU guidance describes concomitant nitrate use as an absolute contraindication to PDE5 inhibitors. The AUA guideline similarly warns that nitrate-containing medicines combined with PDE5 inhibitors can cause a precipitous blood-pressure reduction.
This includes medications used for angina and also recreational nitrate products sometimes called “poppers.” A clinician needs to know about all prescribed, over-the-counter, and recreational substances before recommending an ED medicine.
How Do Diabetes, Blood Pressure and Other Health Conditions Affect ED Treatment?
Chronic health conditions can influence both the cause of ED and the safest treatment. Diabetes, cardiovascular disease, neurological disorders, kidney or liver impairment, and prostate-related conditions deserve particular consideration.
Diabetes and ED
Diabetes can contribute to ED through blood-vessel and nerve damage as well as other metabolic factors. Improving glucose management and addressing cardiovascular risk remain important even when an ED medicine is also used.
PDE5 inhibitors can still be treatment options for many men with diabetes, although individual response varies. Persistent ED should not simply be assumed to be an unavoidable consequence of diabetes.
High blood pressure and ED
High blood pressure itself can contribute to vascular ED, and some medications used for cardiovascular conditions can affect sexual function.
PDE5 inhibitors can generally be used with many antihypertensive medicines, but medication combinations require review because blood-pressure effects can add together. Princeton IV specifically examined PDE5-inhibitor use alongside common cardiovascular medicines and found them broadly safe in appropriately selected patients, while retaining important precautions for nitrates and certain combinations.
Do not stop prescribed blood-pressure medication in an attempt to improve erections without medical advice.
Kidney or liver problems
Kidney and liver function can affect the metabolism and clearance of ED medicines.
The AUA guideline advises caution and initially lower PDE5-inhibitor doses in some men with mild-to-moderate hepatic or renal impairment because drug metabolism may be delayed. More severe disease requires additional individualized assessment.
This is one reason copying another person's ED medication or dose is unsafe.
Prostate problems and prostate cancer treatment
ED may develop after prostate surgery, radiation treatment, or other prostate-cancer therapies. The underlying mechanism and likelihood of spontaneous recovery can differ from ED caused primarily by vascular disease.
Treatment can still involve PDE5 inhibitors, vacuum devices, injections, or implants depending on remaining erectile function and individual goals. A urologist can help establish realistic expectations after prostate treatment.
Men who have both ED and lower urinary tract symptoms from benign prostate enlargement may find tadalafil relevant because it can address both conditions in appropriately selected patients.
How Should ED Treatment Be Matched to Age and Health?
The safest approach is to match treatment to health status and ED cause rather than using an age cutoff. A medication that is reasonable for one 70-year-old may be unsuitable for another 70-year-old taking nitrates or living with unstable cardiovascular disease.
Situation | What should be considered | Possible treatment direction |
Younger adult with persistent ED | Psychological, hormonal, medication and cardiovascular factors | Treat identified contributors; PDE5 inhibitor may be appropriate |
Middle age with diabetes or vascular risk | Glucose, blood pressure, lipids and cardiovascular health | Risk-factor management plus appropriate ED therapy |
Older adult taking several medicines | Interactions, blood pressure, kidney/liver function | Medication review before selecting drug treatment |
Taking nitrates | Serious PDE5-inhibitor interaction | PDE5 inhibitors should not be used; discuss non-PDE5 options |
ED plus urinary symptoms/BPH | Both erectile and urinary symptoms | Tadalafil may be relevant for appropriately selected patients |
After prostate treatment | Nerve and vascular effects, treatment history | Tablets, vacuum therapy, injections or implants depending on circumstances |
Oral medicines ineffective or unsuitable | Correct use, contraindications and treatment preference | Vacuum device, injections or surgical options may be considered |
This framework is general rather than prescriptive. The appropriate drug, formulation, and dose require an individual's medical and medication history.
Does testosterone treatment help ED as men get older?
Testosterone should not be treated as a general anti-aging ED medication. Low testosterone needs appropriate clinical evaluation rather than being assumed from age, fatigue, or erectile symptoms alone.
Current international recommendations suggest considering testosterone treatment in men who have confirmed testosterone deficiency and ED, particularly when response to PDE5 inhibitors is inadequate.
Testosterone therapy is therefore aimed at appropriately diagnosed deficiency, not at producing higher-than-normal testosterone levels for sexual enhancement.
What Lifestyle Changes Can Support ED Treatment?
Lifestyle changes cannot resolve every cause of ED, but they are an important part of treatment when cardiovascular or metabolic risk factors contribute. Current EAU guidance strongly recommends lifestyle changes and risk-factor modification before or alongside ED treatment.
Regular physical activity, smoking cessation, appropriate weight management, healthy blood-pressure and glucose management, and treatment of abnormal cholesterol can support both vascular and overall health.
Lifestyle measures should complement rather than delay treatment of significant underlying disease. Someone with new ED plus cardiovascular risk factors may need medical evaluation even if they are also improving exercise and diet.
Psychological factors also deserve appropriate attention. Anxiety about sexual performance can worsen erectile difficulties regardless of whether the original cause was psychological or physical, and psychological or couples-based treatment can be incorporated when relevant.
When Should You See a Doctor About Erectile Dysfunction?
Persistent or recurrent ED deserves medical assessment, particularly when it is new, unexplained, or accompanied by cardiovascular risk factors. ED is not simply an inevitable consequence of aging, and evaluation can sometimes uncover diabetes, vascular risk, hormonal abnormalities, medication effects, or other treatable contributors.
Seek assessment before using ED medication if you take nitrates, have significant cardiovascular disease, have been advised to limit sexual activity for cardiac reasons, have substantial kidney or liver disease, or take multiple medicines that may affect blood pressure.
Emergency treatment is required for an erection lasting about four hours or longer because prolonged erection, or priapism, can damage penile tissue. Sudden loss of vision or hearing associated with ED medication also requires prompt medical attention.
Avoid unregulated “herbal Viagra” or sexual-enhancement supplements. Products marketed outside normal pharmaceutical controls may contain undeclared drug ingredients, making interactions and dosing unpredictable.
Conclusion
Choosing ED treatment based on age and health means looking beyond the number on your birthday. PDE5 inhibitors are first-line therapy for many men, but cardiovascular status, nitrate use, diabetes, kidney or liver function, prostate treatment history, testosterone deficiency, other medicines, and personal preferences can substantially change the safest approach.
Persistent ED also provides a reason to consider broader cardiovascular and metabolic health rather than treating the symptom alone. If tablets are unsuitable or ineffective, vacuum devices, injections, and penile implants provide established alternatives. A clinician or urologist can review the underlying cause and help select an option that balances effectiveness, safety, convenience, and your treatment goals.
Frequently Asked Questions
1 . What is the safest ED treatment for older men?
There is no single safest treatment based on age alone. Many older men can use PDE5 inhibitors, but nitrates, cardiovascular status, blood pressure, kidney or liver function, and other medications must be considered. Drug-free options such as vacuum devices may suit some men.
2 . Is sildenafil or tadalafil better as you get older?
Neither is universally better for older adults. The choice depends on health, other medicines, desired duration of action, frequency of sexual activity, and treatment response. Tadalafil may have an additional advantage for appropriately selected men who also have urinary symptoms from benign prostate enlargement.
3 . Can you take ED medication if you have high blood pressure?
Many people with controlled hypertension can use PDE5 inhibitors after appropriate assessment. However, these medicines can lower blood pressure and interactions must be reviewed. Nitrate medicines are an absolute contraindication because combining them with PDE5 inhibitors can cause a dangerous blood-pressure drop.
4 . What ED treatment can you use if you take nitrates?
PDE5 inhibitors such as sildenafil and tadalafil should not be combined with nitrates. Non-PDE5 approaches—including vacuum erection devices and, when medically appropriate, alprostadil-based or other specialist treatments—can be discussed with a clinician. Do not stop prescribed nitrates simply to use an ED pill.
5 . Can diabetes-related ED be treated?
Yes. ED associated with diabetes can be treated, although individual responses vary. Management can include improving cardiovascular and metabolic risk factors alongside appropriate ED therapy, including PDE5 inhibitors for suitable patients. Other established options are available when oral medicines are unsuccessful or inappropriate.
6 . When should ED be checked for a heart problem?
New or unexplained ED deserves cardiovascular risk consideration, especially with diabetes, smoking, high blood pressure, abnormal cholesterol, obesity, or reduced exercise tolerance. Current expert guidance recognizes ED as a cardiovascular risk marker and recommends additional cardiovascular assessment for selected men.
Comments